Drug Shortage Report for GD-DICLOFENAC/MISOPROSTOL 50
| Report ID | 220932 |
| Drug Identification Number | 02341689 |
| Brand name | GD-DICLOFENAC/MISOPROSTOL 50 |
| Common or Proper name | GD-DICLOFENAC/MISOPROSTOL |
| Company Name | GENMED A DIVISION OF PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | MISOPROSTOL DICLOFENAC SODIUM |
| Strength(s) | 200MCG 50MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 250's |
| ATC code | M01AB |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-03-08 |
| Actual start date | |
| Estimated end date | 2024-04-19 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-03-09 | English | Compare |
| v2 | 2024-02-29 | French | Compare |
| v1 | 2024-02-29 | English | Compare |
Showing 1 to 3 of 3